Compass Therapeutics (CMPX) Shares Outstanding: 2023-2025
Historic Shares Outstanding for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $177.6 million.
- Compass Therapeutics' Shares Outstanding rose 29.06% to $177.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $177.6 million, marking a year-over-year increase of 29.06%. This contributed to the annual value of $137.8 million for FY2024, which is 7.95% up from last year.
- Latest data reveals that Compass Therapeutics reported Shares Outstanding of $177.6 million as of Q3 2025, which was up 28.41% from $138.3 million recorded in Q2 2025.
- Over the past 5 years, Compass Therapeutics' Shares Outstanding peaked at $177.6 million during Q3 2025, and registered a low of $126.4 million during Q1 2023.
- Over the past 3 years, Compass Therapeutics' median Shares Outstanding value was $137.6 million (recorded in 2024), while the average stood at $137.6 million.
- Data for Compass Therapeutics' Shares Outstanding shows a peak YoY grew of 29.06% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows Compass Therapeutics' Shares Outstanding stood at $127.7 million in 2023, then grew by 7.95% to $137.8 million in 2024, then rose by 29.06% to $177.6 million in 2025.
- Its Shares Outstanding stands at $177.6 million for Q3 2025, versus $138.3 million for Q2 2025 and $138.3 million for Q1 2025.